ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

KINERET
Arthritis/rheumatic disorders
Miscellaneous immune disorders
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

KINERET Rx

Generic Name and Formulations:
Anakinra 100mg/0.67mL; soln for SC inj; preservative-free.

Company:
Sobi, Inc.

Therapeutic Use:

Indications for KINERET:

To reduce signs/symptoms and slow progression of structural damage in moderately to severely active rheumatoid arthritis (RA) that failed DMARD(s), as monotherapy or with DMARDs other than TNF blockers.

Adult:

≥18yrs: 100mg SC once daily. Severe renal impairment or ESRD (CrCl <30mL/min): may consider every other day dosing.

Children:

<18yrs: not recommended.

Contraindications:

Hypersensitivity to E. coli-derived proteins.

Warnings/Precautions:

Increased risk of serious infections; discontinue if develop in RA patients; consider risk vs. benefit in NOMID patients. Active infections: do not initiate. Chronic infections (eg, tuberculosis). Asthma. Immunosuppression. Malignancies. Discontinue if severe hypersensitivity reaction occurs. Monitor neutrophil count at baseline, monthly for first 3 months, then every 3 months for up to 1 year. Renal or hepatic impairment. Elderly. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Concomitant TNF blockers; not recommended. Avoid concurrent live vaccines.

Pharmacological Class:

Interleukin-1 (IL-1) blocker.

Adverse Reactions:

Inj site reactions, upper RTI, headache, nausea, diarrhea, sinusitis, arthralgia, flu-like symptoms, abdominal pain; infections, neutropenia.

How Supplied:

Single-dose syringe—7, 28

Indications for KINERET:

Treatment of Neonatal-Onset Multisystem Inflammatory Disease (NOMID).

Adult:

≥18yrs: not applicable.

Children:

<18yrs: Initially 1–2mg/kg SC daily; may adjust by increments of 0.5–1mg/kg; max 8mg/kg/day. Usually give once daily, but dose may be split into twice daily administration. Severe renal impairment or ESRD (CrCl <30mL/min): may consider every other day dosing.

Contraindications:

Hypersensitivity to E. coli-derived proteins.

Warnings/Precautions:

Increased risk of serious infections; discontinue if develop in RA patients; consider risk vs. benefit in NOMID patients. Active infections: do not initiate. Chronic infections (eg, tuberculosis). Asthma. Immunosuppression. Malignancies. Discontinue if severe hypersensitivity reaction occurs. Monitor neutrophil count at baseline, monthly for first 3 months, then every 3 months for up to 1 year. Renal or hepatic impairment. Elderly. Pregnancy (Cat.B). Nursing mothers.

Interactions:

Concomitant TNF blockers; not recommended. Avoid concurrent live vaccines.

Pharmacological Class:

Interleukin-1 (IL-1) blocker.

Adverse Reactions:

Inj site reactions, upper RTI, headache, nausea, diarrhea, sinusitis, arthralgia, flu-like symptoms, abdominal pain; infections, neutropenia.

How Supplied:

Single-dose syringe—7, 28

Sign Up for Free e-Newsletters

CME Focus